This item is a little shocking:

The overall cost of drugs for type 2 diabetes almost doubled between 2001 and 2007, yet whether these newer drugs improve care and outcomes isn’t known, a new study finds.

In that time period, total spending went from $6.7 billion to $12.5 billion, say researchers from the University of Chicago and Stanford University.

In 2002, diabetes accounted for more than 10 percent of U.S. health-care expenditures, and that number is expected to increase as the number of people with type 2 diabetes grows, the researchers noted.

I’m glad I gave up drinking all those Cokes.